MENS
Jyong Biotech Ltd (MENS)
Healthcare • NASDAQ • $1.74+6.10%
- Symbol
- MENS
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $1.74
- Daily Change
- +6.10%
- Market Cap
- $118.60M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $67.00
- 52W Low
- $1.43
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Company websiteResearch MENS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.